Young Women’s Breast Cancer Translational Program
Call (720) 848-1030 to request an appointment or to find out more.
The Young Women’s Breast Cancer Translational Program (YWBCTP) at the Diane O’Connor Thompson Breast Center is one of the few centers in the country that focuses solely on the unique challenges of young women’s breast cancer and pregnancy-related breast cancer.
Our goal is to raise awareness, and improve prevention, treatment and aftercare for young women’s breast cancer.
What You'll Find Here
Our clinical faculty are experts in the unique challenges that face young women undergoing diagnosis and treatment for breast cancer. Here’s what you can expect.
- The most up to date breast imaging, including digital mammograms and MRIs, as well as minimally invasive diagnostic techniques.
- Comprehensive initial consultations (a visit in which physicians and support specialists from several disciplines are present) to minimize the stress and time required for thorough evaluation and recommendations.
- A dedicated nurse navigator who walks alongside you as a medical advocate from diagnosis to aftercare.
- The latest breast cancer therapy to women diagnosed with breast cancer during pregnancy, to maintain both excellent outcomes for the mother and safety for the developing baby.
- Counseling on what patients can do for themselves in managing the rigors of treatment and the often confusing and difficult road of young women’s breast cancer survivorship.
- A close collaboration in working with our colleagues in Ob/GYN, Hereditary Cancer Clinic, gynecologic oncology, infertility, the Center for Integrated Medicine and with each patient’s primary care providers.
- Our Survivorship Clinic that provides consultation for women ending the active therapy phase of breast cancer.
- A tailored treatment plan and support network for the specific needs of each individual. Our social workers are trained in the unique challenges of young women’s breast cancer, including resources for the significant others and children.
- An extensive list of clinical trials to ensure our patients have access to the latest breast cancer therapies at all stages of diagnosis and treatment.
Our Determined Research Team
The Young Women’s Breast Cancer Translational Research team is focused on identifying why young women’s and pregnancy-associated breast cancer are more aggressive.
We are currently pursuing the role of normal pregnancy-induced immune suppression and post-breast feeding inflammation in pregnancy-associated breast cancer cases. Our researchers have shown for the first time in humans that the post-lactation weaning breast has increased inflammation that could be tumor promoting.
In addition, we are conducting a clinical trial of fish oil and celecoxib (Celebrex™) in women with newly diagnosed breast cancer with the goal of increasing the ability of the immune system to eliminate the cancer.
The fight against young women’s breast cancer is real. And we're determined to ensure our patients aren’t in this battle alone.
Find our ongoing clinical trials in breast cancer
Young Women's Breast Cancer at a Glance
- In 2005, the U.S. was estimated to have 11,110 breast cancer cases identified in women under 40.
- Statistics from similar countries worldwide demonstrate nearly identical rates of breast cancer incidence..
- Despite the recent reduction in total incidence of breast cancer—mostly attributable to women over age 50—the annual incidence in the under-40 age range is actually on the incline.
- Pregnancy-associated breast cancer (PABC) is cancer that is diagnosed in pregnancy or up to six years after birth. These cancers are often more aggressive than those in other women.
- In 2006, when 4.3 million women experienced live births, 25,000 of these women were diagnosed with invasive breast cancer.
- PABC is not a rare event or niche of breast cancer, but a significant subset of the disease that may, in fact, be increasing due to cultural shifts regarding childbearing choices.
Source: American Cancer Society